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1. Introduction 
 
As we all know the strategy of a firm is one of the most important tools to be able to 
strengthen the position on the international marketplace.  
 
But what is strategy?  
 
“Strategy can be defined as the determination of the basic long-term goals and 
objectives of an enterprise, and the adoption of courses of action and the allocation 
of resources necessary for carrying out these goals. Decisions to expand the volume 
of activities, to set up distant plants and offices, to move into new economic 
functions, or to become diversified along many lines of business involve the defining 
of new basic goals. New courses of action must be devised and resources allocated 
and reallocated in order to achieve these goals and to maintain and expand the firm’s 
activities in the new areas in response to shifting demands, changing resources of 
supply, fluctuating economic conditions, new technological developments, and the 
actions of competitors.” (Chandler, 1962: 13) 
 
Because of these factors the management has to obtain the best strategy for the firm. 
But because the environmental factors and organizational capabilities keep changing 
the strategy of the corporation also has to revolutionize. This in turn affects the size 
and structure of the enterprise and the company has to go abroad to be able to 
access larger markets and thus become international. This is the point when the firm 
is considered as a “Multinational Company”.  
 
A. Chandler (1962) was one of the first scientists taking a closer look at the strategic 
tools of companies. In his survey “Strategy and Structure: Chapters in the History of 
the Industrial Enterprise” (1962) he puts up the thesis that structure follows strategy. 
This will be the main part of this thesis, whereas the theory of many other academics 
such as Stopford and Wells, Egelhoff and Bartlett and Ghoshal will also be reviewed, 
to ensure a diversified perspective to this issue.  
 
The main intention of this thesis is to reveal the basic phenomenon of Multinational 
Corporations (MNCs) and their corporate strategy and how strategy can influence the 
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structural appearance of the MNC. The organizational form of this paper is as follows: 
In the preliminary phase I will review the structural analysis of the main forces of the 
theory in order to show the different strategic possibilities on how to manage a firm. 
This will be followed by the explanation of the organizational investigation of the 
structural forms, which can be found either in theory or in empirical studies. The last 
chapter is dedicated to a case study on “Chiesi farmaceutici S. P. A.”.  
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2. Strategic Analysis of Multinational Companies 
 
As the structure of MNCs is a main issue in the scientific literature since the early 
1970s it is imparative to review this chapter in detail. Beginning with the analysis  of 
the different strategic structures mentioned in the early studies, later I will revise 
evolutionary models such as the internationalization model of Stopford and Wells 
(1972), the structural evolution of non conglomerate US multinationals of Daniels, 
Pitts and Tretter (1984) and the relationship model by Egelhoff (1988). Finally I will 
point out the traditional structural forms and I will give a review over the studies of 
Bartlett and Ghoshal.  
 
2.1 Early Strategy Studies  
2.1.1 Chandler’s Strategy-Structure Thesis   
 
Chandler surveyed in the 1960s approximately a hundred of US firms, focusing 
especially on their structural development from 1909 to 1959. During his investigation 
it became evident that changes in corporate strategy led to a transformation of the 
organization’s structure. First the companies started in centralized set ups, because 
most of them just offered one single product or a sole product line, which enabled to 
manage the organization’s strategy tightly. With an increase in demand the 
companies could not afford offering limited product lines. Thus the product lines 
increased and eventually the structural form of the company also had to be adapted 
to ensure the competitive advantage. When the development  of the firm progresses 
further the company has to evaluate product diversification, which implies efficient 
distribution  of resources, coordination between entities and accountability for 
performance (Chandler, 1962). 
 
Robbins (1990) argues in his book “Organization Theory: Structure, Design and 
Applications” that Chandler only focused on large US companies but did not review 
small- and medium-sized organizations to ensure the findings are valid for all firms. 
Another drawback of this survey is that Chandler only focuses on the size of the firms 
but ignoring their profitability, financial strength or the company’s competitive 
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advantage. In the following chapter I will next enlight a multi-dimensional approach 
which also includes the points missing company characteristics of Chandler’s survey. 
 
2.1.2 Miles and Snow’s 4 Strategic Types   
 
In the survey of Miles and Snow et al. (1978) the focus is set on the rate of change of 
the products or markets.  
 
They divide the strategy-types into:  
• Defenders, 
• Prospectors,  
• Analyzers and 
• Reactors 
 
When a company chooses the defender-strategy, trends and developments are 
primarily ignored and the plan is to grow through market penetration and limited 
product improvements. The firm usually has only a few products and is operating in a 
niche market. This position is defended with every possible tool, whether it is very low 
prices or high product quality. The cost efficiency is a key issue, thus centralized 
control, detailed communication protocols and horizontal differentiations are the most 
important strategic patterns of these companies (Robbins, 1990). 
 
Prospectors situate themselves at the other end of the spectrum. They are 
innovators, who try to find new products and seek to exploit new markets. This is the 
reason why innovation overrules profitability. In other words prospectors have a wide 
range of products and they prefer to act instead of react. Therefore the company’s 
most important asset is the employees who find new potential opportunities in the 
environment. Because the people working for such a company have to have the 
freedom to generate new ideas, it is important that this type of firm is flexibly 
structured. As a consequence control is decentralized, communication is not 
standardized and formalization is low (Robbins, 1990). 
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Analyzers try to place themselves in between the two strategies mentioned above. 
Their focus is the minimization of risk and maximization of profits. Well-positioned 
and well-accepted products invented by “prospectors” are imitated after the feasibility 
has been proofed. Because these types of companies are imitators, the profit margin 
is also smaller than those of “prospectors” although the efficiency is higher. Similar to 
the “defenders” position in the market is protected.  
Because these firms are a mixture of defenders and prospectors, they also need a 
diverse strategy structure. Most parts of the systems have to be standardized with a 
high degree of formalization, whereas other parts have to be flexible to ensure the 
dynamics (Robbins, 1990). 
 
Last but not least Miles and Snow mention the reactors. Reactors do not really have 
a strategy, their way of planning only executes poorly. This can be due to 
miscommunication of the management to make the strategy of the firm clear or due 
to the fact that the strategy chosen does not fit the structure of the business 
(Robbins, 1990). 
 
Strategy Goal Structure 
Defender Stability & efficiency 
Centralized, formalization 
high, tight control 
Analyzer Stability & flexibility 
Low centralized control but 
tight control over current 
activities 
Prospector Flexibility 
Decentralized, 
formalization low, low 
division of labour  
Table 1  Strategy Typologies by Miles and Snow  Source: adapted from Robbins 
Stephan P. (1990)  
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2.1.3 Porter’s Competitive Strategies   
 
In his study “Competitive Strategy. Techniques for Analyzing Industries and 
Competitors” (1980) Porter first introduces the 5 forces, which define the competitive 
intensity and the attractiveness of a market. In the second part of his article he 
investigates on the different possibilities to apply the strategy relating to the 
competition.  
 
He identifies three types of strategy: 
 
• Extensive cost leadership 
• Differentiation and 
• Focus 
 
The factor of the cost leadership was initiated in the 1970s. It was important to 
reach a prominence minimizing the costs, no matter if it is the rigorous control of 
variable and general costs or the setup of huge manufacturing plants. The 
dominance of cost reduction in this type of firm is so strong, regardless of how strong 
the price pressure of the competitors are, the company still leaves with a surplus.  
However it is not only the competition that has an influence on the firm, but also the 
suppliers because the firm is still flexible when prices rise.  Another advantage is that 
the entry barriers for other competitors are higher, as it will be hard for them to 
negotiate the same conditions as the company with the cost leadership.  
 
Differentiation is a strategy, where a product is so extraordinary, that no one else in 
the market is able to copy it, especially not the same quality at the same price. This 
product is considered unique. Examples for firms applying this strategy would be: 
Toyota (reliability), Ferrari (performance) or Häagen Dazs (quality ingredients) 
(Robbins, 1990).  
 
The strategy of focus is the last mentioned by Porter (1980). In this case it is 
important to find a niche where the firm can be positioned. The focus is set on the 
satisfaction of needs of this target group. When trying to please customer’s needs 
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and wants the company either differentiates itself or tries to reach a competitive 
advantage by minimizing costs.   
Below the strategy concept of Porter (1980) is visualized.  
 
 
Figure 1  Porter's Three Competitive Strategies   
Source: adapted Porter 1980 
 
 
Porter (1980) also mentions the problem of the so called “stuck in the middle” which 
some companies have to face. These firms cannot gain any competitive advantage 
which hinders them to reach long-term success (Robbins, 1990).  
 
2.1.4 Strategies relating to Management Orientation   
 
Because every company starts business differently and has an altered history, 
variable factors play a major role when considering strategic planning. Reasons could 
be the circumstances of the birth of a firm, the administrative practices, the 
leadership style of the CEO and the company’s culture. Perlmutter (1969) was the 
first author who started distinguishing between the different multinationals. He 
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introduces 4 different executives who all think their company is a multinational 
because they see this as prestigious. They all vary a lot from each other, because 
they concentrate on unequal facts such as organizational structure, nationality of the 
personnel, foreign direct investment, etc. Because "the attitudes men hold are clearly 
more relevant than their passport" (Perlmutter, 1969, pp.11), he presents a scheme 
with three different attitudes regarding various issues, so that this discordance can be 
settled. 
 
2.1.4.1 Ethnocentric Orientation 
 
The ethnocentric attitude can be defined as the home-country oriented. The 
executives’ tenor is that the people from the home-country are supreme and 
authentic. This leads to the fact that most of the people of the headquarters nation 
are hired and the products are home-made because the subsidiaries in other 
countries cannot fabricate the product as good as in headquarter. The consequence 
is that the process flow or the cultures difference are not taken into account, because 
the standard is predetermined by headquarter. Based on the thought "What works at 
home, has to work everywhere around the world!" only people from the home-country 
are recruited, and as a result motivation of the employees in the foreign subsidiaries 
shrinks. 
 
2.1.4.2 Polycentric Orientation 
 
Companies which act upon the polycentric view, have the standpoint that all cultures 
vary und that the customers and employees in the host country are difficult to 
comprehend. So the connotation is that only people from the same country or region 
know how to fulfil the desires and wishes of the customers. The control over the 
subsidiaries is still kept by headquarter. Especially the finance or controlling 
department is located in the home-country and their attitude is to leave the subsidiary 
in peace as long as the profit fits. Because of the polycentric point of view mostly the 
marketing department is located in every country where the firm operates in to make 
the customers feel that the product is national. But the other side of the coin is that 
no local manager will ever move vertically in headquarter. This circumstance results 
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from the fact that “…polycentrism is a virulent ethnocentrism among the country 
managers.” (Perlmutter, 1969, pp.13) 
 
Finally it is important to mention that this orientation is often seen in Europe, because 
the multinationals have a local manager positioned in the host country, who is 
trustworthy and familiar with the local government.  
 
2.1.4.3 Geocentric Orientation 
 
The last point of reference of Perlmutter’s survey is the world-oriented concept, which 
is not defined by nationality but by the qualification and abilities the person has. This 
type of orientation does not focus on the citizenship. In such a company the 
subsidiaries are as important to the whole corporation and headquarter. Thus budget, 
knowhow and information are divided equally. The board’s chairman of Unilever once 
said: “We want to Unileverize our Indians and Indianize our Unileverans.” (Perlmutter, 
1969, pp.13). This involves that subsidiaries are neither seen as ancillaries nor as too 
important affiliates, but belong to the whole system which makes the company work. 
This results in a distinction by function, products or the location. Country managers 
have to find help all over the world to fulfil the wishes and needs of the customers in 
the operating country and this raises the need of increased communication.  
 
In order to motivate the managers of the different subsidiaries not to act 
opportunistically but in the interest of the firm, it is necessary to implement a 
remuneration system.  
Finally Perlmutter (1969) argues that in the geocentric company the nationality is not 
a subject to preferment.  
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Figure 2  Perlmutters Orientations  
Source: adapted from Welge and Holtbrügge 1998: page 54 
 
 
Perlmutter’s (1969) observation was that most MNCs start out with an ethnocentric 
view, slowly evolve to polycentrism and finally adopt geocentrism as the organisation 
familiarises itself more and more with conducting business on a global playing field 
(see figure 3 below). This proofs that the current situation of a firm is not inactive but 
just a point on the time axis during the long time in which the company is more and 
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more changing its attitudes to become a geocentric MNC. But at the same time he 
also mentions that the nationalism is expanding globally and thus this fact is a 
supposition for geocentrism.  
 
Figure 3   The development of the management orientation 
 
 
He even mentions that orientation can vary in different departments of a MNC. As an 
example he points out that the R&D is very often geocentric, the finance department 
contra wise is mostly ethnocentric orientated whereas the marketing section is 
polycentric.  
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The followingis a summary of the payoffs and drawbacks of every form (Hedlund, 
1984, Gomez-Mejia, Balkin, Cardy, 2006):  
 
The ethnocentric orientation:  
 
Advantages:  
• Overcome a potential shortage of qualified managers in host 
countries by expatriating managers from the home country 
• Create a unified corporate culture 
• International marketing 
• Helps transfer core competences more easily by deploying 
nationals throughout the organisation 
• Adaptation on the domestic market 
 
 
Drawbacks:   
• Practices and policies of headquarters become the default 
standards to which all subsidiaries need to comply 
• It can lead to cultural short-sightedness and to not promoting 
the best and the brightest in the company 
 
The polycentric orientation:  
 
Advantages:  
• Local people know what is best for their operation 
• People should be given maximum freedom to run their affairs 
as they see fit 
• Chance of culture myopia 
• Very often less expensive to implement than the other 
strategies, because it needs less expatriate managers to be 
send out 
• Centralised policies are maintained  
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Drawbacks:  
• limited career mobility for both local and foreign employees 
• Isolates headquarters from foreign subsidiaries 
• Reduces opportunities to achieve synergy 
• High possibility of waste of resources 
 
The geocentric orientation:  
 
Advantages:  
• This attitude uses many resources such as human resources 
efficiently 
• Help to build a strong culture and informal management 
networks 
• Recognizes that the key decisions of a multinational should 
be estimated separately according to their impact on every 
country 
• A world adaptation (international network) 
• Global marketing  
 
Drawbacks:  
• National immigration policies may put limits to its 
implementation 
• More expensive compared to polycentrism  
• Global and strategic pacification 
• Treat sometimes the problems of high priority of countries 
host in a marginal way 
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2.1.5 The EPRG Model by Perlmutter and Heenan  
 
In 1979 H. V. Perlmutter and David A. Heenan added in their book “Multinational 
Organisation Development” a fourth orientation to create the EPRG model: the R 
represents the regiocentric approach, which falls in between a polycentric and 
geocentric orientation. This type of course is defined as a functional validation on a 
more-than-one country basis. Subsidiaries are clustered into larger regional units. 
These units correspond with some natural boundaries, such as America and Europe. 
As you can see in table 2 the two mixed approaches request a minimum of corporate 
integration but allow more local responsiveness. 
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 Ethnocentrism Polycentrism Regiocentrism Geocentrism 
Mission Profitability Public acceptance Profitability and Public 
acceptance 
Profitability and 
Public acceptance 
Authority;  
Decision making 
High in HQ; top 
down 
Relatively low in 
HQ; bottom up  
Balanced; mutually 
negotiated between 
regional HQ and 
subsidiaries 
Collaborative 
approach between 
HQ and 
subsidiaries; 
mutually negotiated 
at all levels of firm 
Structure  Hierarchical product 
division 
Hierarchical area 
division with 
autonomous 
national units 
Matrix organization Network 
Control Home standards 
apply for everyone 
no matter of nation 
or race 
Determined locally Determined regionally Standards are 
universal and local 
Communication Orders, Commands 
and advices from 
HQ to subsidiaries 
Little among the 
HQ as well as 
between 
subsidiaries 
High with subsidiaries 
and regional HQ but 
low with mother 
company 
In both directions 
and between the 
subsidiaries 
Identification  Nationality of owner Nationality of host 
country 
Nationality of region International and 
national interests 
Recruiting Employees from 
home country; 
Expatriates 
People from local 
nation  
Employees from the 
region 
Best men counts 
beyond nationality 
Marketing  Needs of home 
country customers 
are decisive for the 
rest of the world 
Local products for 
local needs 
Standardizes within 
region 
universal product 
with local 
deviations 
Finance Profits are returned 
to home country 
Deduction of 
profits in host 
country 
Reallocation within 
region 
Globally equally 
redistributed 
Table 2  Source: adapted from Perlmutter H. V. (1969) and Chakravarthy B. S. and Perlmutter 
H. V. (1985) 
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2.1.6 The Hypermodern MNC- A heterarchical Model by Hedlund 
 
Constitutive on Perlmutter’s EPRG model Hedlund (1986) wrote his article about the 
non-hierarchically organized MNC. He argues that the heterarchical MNC differs 
strategically as well as in the type of structure. A heterarchical MNC seeks to exploit 
competitive advantages gained in the home country and also tries to increase the 
advantages from its global extension. In terms of structure it can be said that the 
heterarchical MNC first classifies its structural properties and then tries to find the 
right strategic option (Hedlund, 1986)   
The main findings of Hedlund (1986) are: 
 
• Because the heterarchical MNC has its competitive advantage in more than 
one country, the firm has many centres. It can also be said that in excessive 
situations one single subsidiary is the centre for performances within one field. 
 
• The centres mentioned above should be different, which means that it 
comprises a mix of organizing standards. So there is no branch or subsidy 
prior to the others.  
 
• The managers of the subsidiaries have a strategic role within the whole MNC, 
and not solely for their own subordinate. Thus the strategy has to be 
formulated and put into practice in a geographically spread network.  
 
• Also the flexibility of the organization plays an important role. A subsidy, for 
example has the opportunity to decide weather it purchases components over 
headquarter or externally. However it is not only the freedom of purchase but 
also the flexibility to choose the governance mode. Thus the heterarchical 
MNC has the opportunity to externalize production or contract a joint venture, 
without the need of strong communication with headquarter.  
 
• Another important issue is that information is not centred in headquarter but 
every subsidiary has the same Know-How-level of the company’s business. 
Because of this the knowledge generation is not only placed in the centre but 
every branch is welcome to generate new ideas.  
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• Last but not least Hedlund (1984) mentions that alliances with other firms are 
rather common in a company following the heterarchical mindset.  
 
• In terms of Human Resource Management it can shortly be said that the 
employees are one of the main corporate advantages of the firm. Thus the 
core of the heterarchical MNC is the member of staff, who can provide long 
experience. The motivation of these people cannot only be achieved by simply 
promoting them but by enabling to move between the centres. This leads to a 
heavy shifting in personnel.  
 
2.1.7 Linking the EPRG Model to other theories 
 
2.1.7.1 Linking the EPRG to Product Life Cycle 
 
This theory can also be combined with the supposition of Vernons product life cycle 
model (Melin 1992: 103). The first stage of the product life cycle is the introduction. 
This phase is characterized by the fact that the product is unknown to customers and 
requests high marketing efforts to promote the item. Because this needs heavy 
investment, the firm will probably do this in the home market and thus have an 
ethnocentric orientation.  
After establishing the product the growing stage will begin, which is the time when 
sales rise and direct competition starts. According to Melin (1992) exports will start off 
and foreign direct investment will increase especially in overseas markets where the 
demand for the product is expected to be higher than in the home country. So this 
phase can be identified as a mixture of a polycentric and a regiocentric orientation 
because the firm will peel off its focus on the home market and also concentrate on 
the needs of the foreign customers. As the company has probably no awareness of 
the overseas culture, it will employ people from the local nation, who are familiar with 
the wishes and needs of their own public. 
 
The next stage is the maturity phase, where sales are constant and some 
competitors are forced to leave the market, because the main markets are mature 
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and the company’s product is standardized over the globe. This phase can be 
identified as the geocentric approach, since it is a universal product with local 
deviations.  
 
In the final phase of the circle the product will die due to too high competition, poor 
state of economy or new trends, which the firm does not realize.  
 
 
Figure 4 Possible connections between the management orientation and the product life 
cycle 
 
2.1.7.2 Linking the EPRG with Marketing Orientation 
 
In an earlier survey H. V. Perlmutter, Y. Wind and S. P. Douglas (1973) also 
published a paper concentrating on the EPRG model and relating it to marketing 
issues. According to the authors, the attitude of the MNC depends on different 
factors, which have to be taken into account: One is the size of the company. A small 
firm, which is most likely ethnocentric oriented, will make inroads into a market, with 
similar needs of the customers. Bigger firms instead have higher funds and thus can 
do more research in foreign markets. This allows to implement a more geocentric 
management style.  
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The second fact mentioned by Wind et al. (1973) is the experience gathered in the 
foreign market. A firm takes less risk when entering an overseas market with an 
ethnocentric attitude, because further development and research, which includes 
higher costs, is not necessary. Although when Know-How and experience will be 
necessary, deciding to apply a geocentric strategy.  
 
The next item is the size and degree of heterogeneity of the potential market.  If the 
market overseas is smaller than the domestic, it will not make too much sense to 
propose a special strategy for this market, because the costs would in all likelihood 
exceed the revenues. But whenever sales rise segmentation will be relevant to meet 
the customers taste.    
 
Overall it is important to mention the fact that the nature of the product also has to be 
considered. Different cultures have different tastes and regulations and this has to be 
taken into account.  For examples in the food industry: An Indian company will not be 
able to sell the same spicy dish in Europe like in the home country because the 
flavouring differs.  
 
According to Wind et al. (1973) the perfect EPRG mix cannot be identified, but the 
positioning rather depends on the individual company, its intentions and the particular 
situation. They suggest first to settle on the degree of involvement in the 
internationalization of the firm and then set Marketing targets within the limitations of 
the chosen strategy. Nevertheless, as you can see in figure 5 the ethnocentric 
orientation has no target to reach. This is due to the fact that customers’ needs and 
desires are not investigated in the foreign country and thus the marketing efforts of 
this firm are relatively low.  
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Figure 5 Relationship between Marketing and Management Orientation  
Source: adapted from Wind, Douglas and Perlmutter 1973: page 22 
 
2.1.7.1 Linking the Management Orientation to the corporate structure 
 
In their survey “A Strategic Contingency Model of Multinational Corporate Structure” 
Lemak and Bracker (1988) link the management orientation of Perlmutter with the 
possible corporate structures by the findings of reviewed literature. Their model starts 
with the generic strategy of a MNC. In this stage the main focus is the volume 
maximization, which is the effort to make returns by increasing the volume of export 
for finished goods and the increase of value added while at the same time 
decreasing the rate of imports of raw materials. The next steps expressed by this 
model are the domain parameters. In this phase the product diversity and the 
dependence on foreign operations is taken into account. Then it is the management 
orientation by Perlmutter which influences the strategic contingency model.  Finally 
the corporate structure can be defined. When combining the management orientation 
and the multinational corporate structure there can be found two different groupings. 
These 24 possible mixtures can be seen in figure 6 and figure 7, which I will not 
mention in detail.  
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Figure 6 Volume Maximization Strategy 
Source: adapted from Lemak and Bracker 1988: page 524 
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Figure 7 Value Added Startegy 
Source: adapted from Lemak and Bracker 1988: page 525 
 
 
It is important to focus on the hypothesis assumed by Lemak and Bracker (1988).  
Their first hypothesis is that ethnocentric firms will only operate in a product, 
functional or international division, but never in an area or matrix division. This can be 
seen as the result of the spotlighting of the companies management to centralize the 
decision making because when the decision making force is concentrated in the 
home office, the focus is either on the product or on the function, which might be the 
corporate advantage of the firm.  
 
The second interesting proposition is that a geocentric oriented company will in all 
probability implement an area structure since it wishes to encourage the 
decentralization of the management. But the corporation might also choose the 
international division in order to avoid complicated operations in the host countries, 
when the complexity reaches a high level.  
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Also worth mentioning is the theory that the speed of the companies growth might 
play a role when looking at the structure in conjunction with the orientation. According 
to Lemak and Bracker (1988) when a firm expands slowly and does not need to 
implicate a lot of structural changes it can keep the decisions in the home country 
and thus be ethnocentric. But when the expansion is rapid the management does not 
have enough time to execute every single decision by the home office and eventually 
will need to rely on the employees in the host country. This means that the orientation 
of the firm is therefore geocentric.  
 
The only missing aspect of this survey is that all these interesting hypotheses are not 
materially documented because there is no empirical study added.  
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3. Structural Analysis of Multinational Companies 
 
3.1 Evolutionary Models  
 
Westney and Zaheer (2003) state in their article “The Multinational Enterprise as an 
Organization” that the structural change of multinational companies can be shown by 
means of evolutionary model. There can be found three improvements, the evolution 
of formal structures, the evolution of companies’ value adding activities and the 
evolution of managerial style.    
 
3.1.1 Internationalization Model by Stopford and Wells   
 
Stopford and Wells (1972) build their model up on the survey of Alfred Chandler 
(1962). They created a model for internationalization possibilities of companies. In 
this presentation there are two factors, which can be seen as the main drivers. The 
first is the size of a company and the second the product diversity.  
 
As you can see in figure 8 a company starts with a relatively low level of foreign 
sales. As time passes the product diversity increases, because the firm expands the 
product portfolio and through this implements an international division structure. 
This stage then will be followed by two different opportunities. The MNC can either 
decide to focus on the product diversity, which would end in a worldwide product 
division structure or to focus on foreign sales, in which the firm should implement 
an area division structure. But no matter which path the company chooses to go 
they would, according to Stopford and Wells (1972) end in a global matrix 
structure. The only pitfall of their survey was that they could not find one company 
using this global matrix structure in real life (Westney and Zaheer, 2003). 
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Figure 8 Model of Internationalization 
Source: adapted Stopford and Wells 1972 
 
 
3.1.2 Structural Evolution by Daniels, Pitts and Tretter   
 
Another survey which can be added to the group of evolutionary models is the one of 
Daniels, Pitts and Tretter (1984). In this case 93 large U.S. MNCs were surveyed. 
The main foci were the operating characteristics and the multinationals structures. 
Building on the theses of Chandler (1962) and Stopford and Wells (1972) the authors 
could outline the following hypotheses:  
Companies with low level of product diversity will apply functional structures, whereas 
firms with an idiosyncratic product diversity altitude will use product structures. Finally 
it can be said that wherever foreign sales are high an area division structure is 
initiated.  Every other mixture of orientation can be summarized as an international 
division structure (Daniels, Pitts and Tretter, 1984).  
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Figure 9 Structural Evolutions of Non-Conglomerates US Multinationals   
Source: adapted from Daniels, Pitts and Tretter (1984) 
 
3.1.3 Strategy-Structure Model by Egelhoff  
 
Egelhoff (1988) adapts the study of Stopford and Wells (1972) by studying 34 US 
and European MNC and so presenting a new model with three similar dimensions, 
which are modified a little.  As you can see in figure 10 below just like the study of 
Stopford and Wells (1972) it presents firms with a relatively low percentage of foreign 
sales and low product diversity that will implement an international division structure. 
But Egelhoff (1988) could not find any MNC applying the worldwide product division 
in his set. So he was not able to proof or to vitiate the findings of Stopford and Wells 
(1972).  
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When considering the second stature in figure 10, Egelhoff contemplates the 
situation as soon as the percentage of foreign sales is high. In this case he argues 
that the coordination and information processing between headquarters and the 
subsidiaries rise and thus a worldwide product division has to be adopted. So 
strategies with high product diversity and a lot of exports from the head office to 
supplementary have to be considered.  According to Egelhoff this can be called a 
global strategy which leaves no room for national or regional responsiveness.  
Subsidiaries are relatively independent, when the strategy entails a lot of 
manufacturing to help expand foreign sales. This ends in a lower operational effort 
what in turn leads to higher regional and national responsiveness. The firm applying 
this strategy will have an area division.  
The last strategy discussed by Egelhoff (1988) is the one, which involves high levels 
of foreign product diversity and high percentage of foreign manufacturing. Thus a 
mixture of product division and area division strategy will be the best for this company 
because the dependency on headquarter is, on the one hand high regarding 
knowledge transfer, and on the other hand low because the synergy effects with 
neighbour subsidiaries are used.  
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Figure 10 Revised Model showing the relationship between strategy and structure in MNC 
Source: adapted from Egelhoff (1988) 
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3.2 Traditional Structure Figures 
 
The intention of this chapter is to show through authors such as Franko (1976), 
Hedlund (1984) or Wolf and Egelhoff (2001, 2002), who did reviews of European 
companies, how important the structural form of a MNC is. The traditional forms, 
which will be analyzed step by step in this section, differ slightly of those shown by 
researchers form the US.  
 
3.2.1 The Mother-Daughter Structure 
 
The most representative author in the context of the mother-daughter structure is 
Lawrence G. Franko (1976), who had his focus on MNCs located in Europe.  
According to him most of the continental MNCs in 1971 had this type of 
organizational form. An adumbration of such a MNC is shown in figure 11.  
 
 
Figure 11 The mother-daughter structure in MNC 
Source: adapted from Franko (1976) 
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When a MNC applies the mother-daughter structure, management practices are kept 
relatively informal (Franko, 1976). This means that the relationship between 
headquarters and subsidiaries is personalized and there is not a lot of attention paid 
on written rules and standardization. The independence of the subordinates is put in 
foreground but the reports still have to be send directly to the CEO located at 
headquarter (Hedlund, 1984). Thus the managerial focus is set on home-country 
expatriates as managers or directors for subsidiaries.  
 
The key findings of Franko can be summarized the following way (Hedlund, 1984; 
Gilligan and Hird, 1986):  
 
• Subsidiaries report directly to headquarter 
• Subsidiaries are relatively sovereign 
• Relationship between headquarters and subsidiaries are personalized 
and informal 
• Personnel rotation is used as a management tool 
• Most of the companies applying the mother-daughter structure have 
quite narrow product lines 
 
The result of Hedlund’s case study of four Swedish MNCs was that the most common 
way is to apply a mixture of mother-daughter structure and global product division 
structure. But the propensity is to move more and more towards “exlicid and formal 
formulation of goals for foreign subsidiaries by central headquarters” ( Hedlund, 1984: 
122).  
 
3.2.2 The International Division Structure 
 
The international division structure is an often used structural form. It is mostly 
applied when companies sell domestically produced goods in foreign markets 
(Stopford and Wells, 1972, Hill and Jones, 2007, Daniels, Pitts and Tretter, 1984). 
This is due to a low level of foreign sales and low product diversity used abroad. This 
in turn forces headquarter to keep control centralized and because of a high degree 
of formal rules the information flow from the main establishment to the subsidiaries is 
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comparatively slow (Stopford and Wells, 1972). Furthermore it is important to 
mention that since control and coordination are kept pivotal the customization is 
minimal and the subsidiary has only the opportunity to handle local sales and 
distributions (Hill and Jones, 2007).  
 
The international division structure develops to be gratuitous when the 
internationalization of the firm progresses, which means that the MNC becomes more 
and more incorporated in a foreign country.  No matter if it is the study of Stopford 
and Wells (1972) or the one of Franko (1976), they all come to the conclusion that 
most of the multinational companies, regardless if located in the United States or in 
Europe, change their structure from the international division after some period of 
time. This change in structure can either be an alteration toward a global structure or 
a modification to a mixture area or product based strategy (Stopford and Wells, 
1972).  
 
 
 
Figure 12 The international division structure in MNC 
Source: adapted from Hill and Jones (2007)  
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3.2.3 The Global Product Division Structure 
 
When the cost-pressure rises (which means that expenses have to be reduced) but 
the demand of local responsiveness is low, a firm will adopt the global strategy. More 
precisely it can be said that when the diversification of product lines rises, the MNC 
will most probably assume a global product division structure. This structural form 
implies that the product is manufactured for a global market.  
 
The most important paper in this respect is the one of Davidson and Haspeslagh 
(1982). In their survey they come to the conclusion that the global product structure 
“…promotes cost efficiency in existing products for existing markets” and “helps 
companies consolidate their positions in mature and stable markets…” (Davidson 
and Haspeslagh, 1982: 125)  
Another advantage would be that firms, which face a change in sales, which means 
when the overturn of the home product division is less than the one of the foreign 
market, lean towards a global product division structure, because they hope to gain 
cost efficiency, resource transfer and progressed communication (Stopford and 
Wells, 1972).  
 
Davidson and Haspeslagh (1982) in turn also mention the drawbacks. These can be 
summarized as:  
 
• Retarded transfer of resources aboard 
• Defensive competing position of the firm 
• Lower foreign sales feature 
• Focus on international experience, responsiveness and recommendation 
needed 
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Figure 13 The global division structure 
Source: adapted from Hill and Jones (2007)  
 
3.2.4 The Area Division Structure 
 
As already mentioned earlier, Stopford and Wells (1972) argue that an area division 
structure is used in companies, which face an increase in foreign sales but have a 
slim product line. This is applied if the size of the international division is bigger than 
the one of the domestic. Egelhoff (1988) criticises that is not only the size that 
matters, but also the level of foreign manufacturing plants have to be taken into 
account.  
 
In an area division structured company, the firm splits its distributions either by 
countries or by regions.  The divisional size depends on the volume of the market. 
The headquarters are located in each region, and the different regions have the 
possibility to act in a self-governing way, which means that the actions in the different 
parts, such as marketing, finance or R&D, are adapted to the need of the region or 
country (Harzing and Ruysseveldt, 2004). 
 
As a drawback it can be said that “…this type of structure suffers from a lack of 
coordination.” (Harzing and Ruysseveldt, 2004: 43) because the efforts have to be 
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taken in every single area, without taking into account those synergies could be 
exploited. To avoid duplication firms employ staff specialists, who smooth the 
progress of information transfer (Harzing and Ruysseveldt, 2004).  
 
 
Figure 14 The area division structure 
Source: adapted from Westney and Zaheer (2003) 
 
3.2.5 The Matrix Structure 
 
When looking at the internationalization model by Stopford and Wells (1972) one 
realizes that no matter which path (worldwide product division or area division) the 
company chooses to go it would end in a global matrix structure. So how can this 
type of structure be defined? As soon as a firm applies the matrix structure both 
foreign sales and product diversity are high. Thus the benefit is identified as the 
combination of the improvements of the area and the worldwide product structure 
(Westney and Zaheer, 2003). So in these decisions the local responsiveness and the 
global efficiency are united. Because these two facts are combined the responsibility 
of a special market has to be divided by the product and area manager. The negative 
aspect is that coordination costs and bureaucracy are high which makes the MNC 
slowly acting and the company looses the ability to react to market changes fast 
enough (Harzing and Ruysseveldt, 2004). 
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When looking at the practical experience neither Stopford and Wells (1972) nor 
Daniels, Pitts and Tretter (1984) could find enough companies applying this 
organizational form to ensure a valid and significant sample.  Later Daniels, Pitts and 
Tretter (1985) did a survey with a sample of 56 MNCs from the Fortune 500 list. Even 
in this survey they were only able to find one single firm which deployed the matrix 
structure. According to the authors the explanation for this would be that corporations 
with this type of organizational structure are heavily subjected to technical and 
environmental complexities, they are unenthusiastic to revolutionize any operational 
and structural changes. These firms prefer to wait for another company to start.  
 
 
Figure 15 The matrix structure 
Source: adapted from Westney and Zaheer (2003) 
 
 
In 2002 Wolf and Egelhoff did a survey on 95 different German companies, 
whereupon two third characterize themselves as matrix structured. This matrix 
structure was not only the mixtures mentioned in older studies, but there were also 
matrices found combining functional and product divisions or combining functional 
and area divisions.  These different combinations are essential to maintain the 
advantages gained and to be able to stay flexible enough in order to act to trends 
(Wolf and Egelhoff, 2002).  
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The main drawbacks of this organizational form are summarized by Daft (1995). As 
also already mentioned earlier one big disadvantage of a matrix structure is that the 
company cannot act fast and flexible enough to environmental changes or changes 
of customers tastes. Another important fact which needs to be mentioned is that the 
decision makers can be overloaded with information and others who would need this 
knowledge would be left out. It could also happen that the wrong employees are 
positioned at the incorrect location (Daft, 1995).  
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3.3 The Organizational Model by Bartlett and Ghoshal  
 
Due to the continuing change of the Multinationals towards globalization, the 
organizational models evolved. The 1980s were rough times for companies 
“…playing the game of global chess…” (Bartlett and Ghoshal, 1989: 13). The 
companies had to find the balance between global integration and local 
responsiveness, since the main barrier to globalization is located in differences of 
national market structures and consumer preferences. Thus they were forced to 
adopt the best possible strategic orientation (Bartlett and Ghoshal, 1989).  
 
Bartlett and Ghoshal (1989) studied nine different companies operating in different 
markets and having different capabilities which can be found in figure 16. These nine 
MNCs can be divided into three main groups according to their structural 
configurations, their different administrative processes and managing mentalities.  In 
the following subsections I will look at these three structural organizational models 
into more detail.  
 
 
Figure 16 The nine Companies of the Study of Bartlett and Ghoshal 
Source: adapted from Bartlett and Ghoshal (1989) 
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3.3.1 The Multinational Organization Model 
 
The Multinational Organization or in other words the decentralized federation was 
mostly found in European companies, which were expanding into foreign markets. 
These firms were leaded by family members and thus formal structures were hard to 
find. It can even be said that when external personnel was needed the management 
chose to delegate independence to trusted employees. This way control and 
coordination were primarily achieved through personal relationship. All in all Bartlett 
and Ghoshal mention the following characteristics of the decentralized federation: 
“…decentralized federation of assets and responsibilities, a management process, 
defined by simple financial control systems overlaid on informal personal 
coordination, and a dominant strategic mentality that viewed the company’s 
worldwide operations as a portfolio of national business.” (Bartlett and Ghoshal, 
1989: 49). Below in figure 17 these structure can be found graphically. 
 
 
Figure 17 The Multinational Organization Model  
Source: adapted from Bartlett and Ghoshal (1989) 
 
Westney and Zaheer (2003) additionally mention that this type of orientation also 
implies that the company outsourced responsibility to local markets. Furthermore it is 
pointed out that the knowledge developed in the subsidiaries stays there.  
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3.3.2 The International Organization Model 
 
According to Bartlett and Ghoshal (1989) the second type of strategy which could be 
found was the one of companies after the Second World War, which were 
internationalized. The focus was set on transferring knowledge and expertise from 
the home country to the less developed countries according to their progress in 
technology or market improvement. This was most often applied by US-companies. 
Coordination and control of the subsidiaries needed much more effort of 
headquarters, due to the dependence on the mother company when new products or 
processes were developed. Bartlett and Ghoshal also call this type of orientation the 
coordinated federation. Below this organizational model is demonstrated graphically.  
 
 
Figure 18 The International Organization Model 
Source: adapted from Bartlett and Ghoshal (1989) 
 
Another important fact is that the main strategy is centrally generated. Knowledge, 
technology and management systems are home-generated and it is headquarter, 
that decides, which subsidiary receives which help.  
Thus nearly the full value chain is generated at the subordinates and they are not too 
dependent on resources (Westney and Zaheer, 2003).  Because of this the strategy 
is also called the Coordinated Federation (Bartlett and Ghoshal, 1989). 
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3.3.3 The Global Organization Model 
 
This form of organization was first applied by Henry Ford and John D. Rockefeller. 
The main focus was set on the production of standardized goods which were shipped 
over the whole world. This was done with a tightly centrally controlled tool (Bartlett 
and Ghoshal, 1989). The subsidiaries had no authority and were contingent upon 
headquarter (Westney and Zaheer, 2003). The only purpose of the subordinates is to 
enlarge the sales and implement the strategy and rules of the mother unit. There is 
no freedom for developing or producing new products. Because of this tight 
organizational structure Bartlett and Ghoshal also call this type the Centralized Hub.  
A lot of Japanese companies applied the Global Organization Model in the 1970s 
and early 1980s. Bartlett and Ghoshal explain that since the culturally dependent 
management system was based on group oriented behaviour and because of the 
complex cultural communication norms it was hard to transfer these to the 
subsidiaries. Thus all decisions were made centrally and delegated abroad. This in 
turn made it necessary that control was tight.  
As another effect the managers in headquarters had to think globally and could not 
rely on the subsidiaries, which in turn made the leadership focus less on local 
environmental specialities (Bartlett and Ghoshal, 1989). 
Westney and Zaheer (2003) go even one step further and argue that this type of 
orientation is globally integrated with the search for economies of scale.  
 
Figure 19 The Global Organization Model 
Source: adapted from Bartlett and Ghoshal (1989) 
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4. The Triad Power 
 
When companies started to go abroad they had to rethink their strategy. Kenichi 
Ohmae (1985) made the word “Triad” the most popular one in connection with 
regional strategies. According to Segal-Horn and Faulkner (2000) the triad are 
different trading blocs in the most developed regions of the economic world; these 
are Europe, Asia and North America.  
 
 
 
Figure 20 The Triad Power 
Source: adapted from Segal-Horn and Faulkner 2000 
 
Rugman and Verbeke (2004) describe the historic emergence of this phenomenon: 
Because of the floating of the dollar the domination of US firms ended in the 1970s. 
So the outward investments of companies located in the United States declined to 
the half within 25 years until 1990. In 1985 then Kenichi Ohmae published his study 
presenting the Triad, which was a geographic space consisting of the United States, 
Europe and Japan. These regions had some common grounds: “…low 
macroeconomic growth, a similar technological infrastructure, the presence of large, 
both capital- and knowledge-intensive, firms in most countries, a relative 
homogenization of demand … and protectionist pressures” (Rugman and Verbeke, 
2004: 4)  
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Segal-Horn and Faulkner (2000) argue in their book that there is not only the trade 
between these blocks but also the intra-regional trade, which is quite important for 
some regions and worth mentioning. An example would be the intra-Mercosur trade 
especially between Brazil and Argentina which has boosted from 4 billion US$ in 
1990 to approximately 14.5 billion US$ 5 years later. But it is fundamental in this 
context to also point out that the inter-regional trade between the EU and the 
Mercosur in 2007 was € 32.12 billion (exports to Mercosur countries) respectively € 
47.84 billion (imports from Mercosur countries) (website of the European 
Commission).   
 
There is also evidence to this fact by the survey of Fontagné et al. (2005). The 
authors have examined in this paper the trade flows between the three blocks on one 
hand and on the other hand have surveyed weather protection mechanisms like 
tariffs or trade barriers influence the trade through bilateral trade and production 
figures in companionable industries taken from the “Trade and Production 1976-99” 
database of the World Bank. In this context Fontagné et al. mention that it can be 
observed that trade volumes are doubled when the interacting countries speak the 
same language, which can be seen as an important factor for the traffic of goods and 
services. This will be laid out in more detail at a later stage.  
 
But it is not the only focus of Fontagné et al.: They also look at the different 
industries. According to the authors the transport equipment, industrial chemicals and 
professional and scientific equipment are industries which face less border effects 
than manufacturing such as wood, furniture or food.  
 
Finally they to come to the conclusion that  whenever the final demand of a country is 
high and powerful, the enterprise actions more home oriented and the Triad is no 
longer important.  
 
Rugman and Verbeke (2004) have taken a closer look at the phenomenon of the 
Triad and have tried to find an empirical evidence of triad power. For this reason they 
have taken a closer look at the world’s largest 500 companies which where also the 
“Fortune 500” that they regard as MNEs. These are defined as: “…they produce 
and/or distribute products and/or services across national borders.” (Rugman and 
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Verbeke 2004: 6). Due to the absence of information and the absence of international 
trade only 365 companies where left for further appraisal. After surveying these firms, 
the authors where only able to identify 9 global MNCs, which had not less than 20% 
of their sales in all three regions of the triad. Most of the companies (320 firms, which 
make about 80%) were home region oriented. But still it is important to mention that 
for these numbers Rugman and Verbeke have only considered trade, which is easier 
to calculate with, but there is more that has to be taken into account when talking 
about internationalization. However this will be laid out in more detail at a later stage.  
Making allowance to these figures it shows that firms cannot be regarded as 
international only because they export products. Because most corporations are 
home country oriented they have a weak market position in host regions and this is 
caused through regionally based action.  
 
In their survey Poon, Thompson and Kelly analyze, if there is a triad, when 
concentrating on trade on one hand and foreign direct investment on the other. For 
this reason they linked the year 1985 to 1995 pulling out the data from International 
Monetary Fund’s “Direction of Trade Statistics” and OECD’s 1997 “International 
Direct Investment Yearbook”.  
 
In respect to trade they discovered out that in 1985 there were seven regional 
clusters: the US, Brazil, Japan, Germany, France, UK and the former USSR.  These 
regions dominated the trade in the past, and in Europe there were even 4 countries 
dominating the trade. These countries showed up a high geographical and historical 
cause. Especially in the case of France and the UK the colonial time plays an 
important role.  
 
Ten years later the political situation had changed a lot and some main trade forces 
could be found any more. An example was the USSR, which lost its monopoly power 
after the breakdown of the communism. According to Poon, Thompson and Kelly in 
the year 1995 there are only four regions left, which can demonstrate even stronger 
power in the world market. The region in which the US was dominating, enlarged by 
Latin America it was present in every country in North and South America. Brazil 
completely lost its power as a driving force. 
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A big winner of political changes was Germany. This nation extended its power not 
just in Europe and the ex-communistic countries but also in regions where Brazil was 
based, such as Iraq, Iran, Jordan, Syria and Israel. Also all the French dominated 
states swapped their trade partner and thus the French predominance disappeared 
until 1995.  
 
The second main driving force in Europe in the nineties was the UK, which could 
enlarge its power in the former USSR.  
The situation for Japan as the key power house in Asia did not change a lot within 
this period of time, except that India also enforced its trade with Japan.  
 
Concerning foreign direct investment patterns Poon, Thompson and Kelly write that 
they are more geographically concentrated than trade, because most of the MNCs 
are scattered all over the world and thus are also the investment decisions.  
 
According to the authors in 1985 there could be found five main regions, which were 
the main drivers of foreign direct investment. These countries were Japan, the US, 
Germany, France and Sweden. Especially the last two mentioned had the highest 
interaction intensities with their partners, particularly in the former communistic 
countries such as USSR, Poland, Czechoslovakia and Hungary.  
 
Ten years later these highly investing countries cannot be found any longer in the 
survey of Poon, Thompson and Kelly. In 1995 there are only four centres which drive 
the FDI Patterns. Japan, the US, Germany and Switzerland can be found as major 
investors in the global financial market. At the same time it is Japan that is staking at 
a high level with its partners, which are nations such as China, Malaysia and 
Indonesia. But it was also possible for Germany to spread its influence in the FDI 
sector of different countries, especially in Islamic states such as Turkey, Iran, and 
Libya.  
 
Finally Poon, Thompson and Kelly argue that it is wrong to think that propinquity 
plays a key role in foreign direct investment decisions, because it can be seen that a 
company can easily separate the production from the rest of the organisation and 
thus FDI determinations can be made easily all over the globe.  
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The concluding words of the authors are that it can not be seen empirically that there 
is any triad power neither in trade nor in foreign direct investment issues since 
Kenichi Ohmae presented his thesis.   
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5. Case Study of Chiesi farmaceutici S. P. A. 
 
 
 
 
 
5.1 Methodology  
 
Case study research is one possible method in social science next to experiments, 
surveys, archival analysis and history. But why did I choose the technique of a case 
study?  
The key aim of a case study is to try “…to illuminate a decision or a set of decisions: 
why they were taken, how they were implemented and with what result.” (Schramm, 
cited from Yin, 2009). Thus it is the how and why which is put in spotlight. One can 
say that it is more explanatory than the other forms of research (Yin, 2009).  
 
In the following table the strengths and weaknesses of theory building from case 
studies are denoted: 
 
 Strengths  Weaknesses 
New Theory Likelihood of generating new 
theory 
Theory which is rich in detail, 
but lacks simplicity of overall 
perspective 
Testability of Theory  Likelihood of testable theory 
because of already measures 
and hypotheses that are 
already proven 
 
Empirical Validity  Likelihood that the results are 
empirically valid 
Theory describes only a specific 
occurrence  
Table 3  Strengths and Weaknesses of Case Study Research 
 Source: adapted from Eisenhardt (1989)  
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An interview with professionals Alessandro Chiesi, Affiliate Coordinator International 
Division (Italy), and Wolfgang Harrer, Managing Director of Torrex-Chiesi located in 
Austria, did take place on the 12th of March 2010 to show the different strategic 
stages of a MNC in the pharmaceutical industry. First the interview conducted and 
then I will show the stages Chiesi farmaceutici S. P. A. is in according the information 
gathered during the questionnaire matched with the theoretical parts of this theses.  
 
5.2 History of Chiesi farmaceutici S. P. A.  
The Chiesi group dates back to the 30ies, when Giacomo Chiesi, a pharmacist, 
bought a pharmaceutical laboratory located in Parma on the 6th of July 1935. The 
young entrepreneurship started with 2 employees and Giacomo Chiesi first exported 
self-produced pharmaceutical goods to Eritrea and Austria in 1940.  
During World War II some parts of the company were destroyed and thus the post-
war-time was used to rebuild the plant and to strengthen the position of the company 
in the main fields acting.  
In 1955 Chiesi was relaunched and the numbers of the employees rose to around 
fifty.  A decade later in 1965 the incorporator handed the management over to his 
sons Alberto and Paolo Chiesi, who are still directing the board.  
At the end of the 1970's when the first foreign subsidiary in Brazil was opened, the 
company began to become an international company. It was in 1979 when the first 
corporate product was developed, which was a cortisone preparation for asthma and 
respiratory disorders. Since this time the main field Chiesi is acting in is the 
respiratory segment.  
Pakistan was the next region Chiesi expanded to. Starting with export they later 
opened a branch there.  
In the 1990ies Chiesi started its extensive expansion in Europe by firstly buying 
Promedica, a small French company, which was also specialized in the respiratory 
segment. From this time on Chiesi could not be stopped growing whether by 
acquisition or by opening subsidiaries within Europe. A key acquisition was the one in 
Austria. By buying Torrex, Chiesi could enter the market in Eastern Europe using the 
numerous products registered by them.  
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They also expanded beyond Europe. In 2002 the main products were registered in 
the U.S. market and in 2004 the operation in North Africa began. Last but not least 
Chiesi started its business in May 2008 in China. 
Today the Chiesi group operates in five continents with 23 direct branches and 
manufactures and distributes its pharmaceutical products in over 60 countries 
(Website of Chiesi farmaceutici S. P. A. http://www.chiesi.com; access date: 
2010/04/14).  
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5.3 Numbers and figures of Chiesi farmaceutici S. P. A.  
 
Chiesi farmaceutici S.P.A. is a company which was able to steadily increase its 
revenues in the past years. As one can see in figure 21 the revenues of the group 
keep rising each year. Even during the economic crisis of the years 2008/2009 the 
percentage of sales growth augmented. In 2007 the revenues rose by 10.6% and in 
2008 even by 14.1%. The latest numbers for 2009 were sales of € 872 million with a 
growth of 16.5% in 2008, approximately three times the average of the world market 
(Chiesi farmaceutici S.P.A., Massimo Zaninelli, Corporate communication manager).  
 
 
 
 
Figure 21 Operating Results of Chiesi farmaceutici S.P.A. 
Source: Annual Report of Chiesi farmaceutici S.P.A. 2008 
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Figure 22 shows the different therapeutic areas Chiesi farmaceutici S.P.A. is acting 
in. The main part of the corporation is the respiratory sector, which makes nearly the 
half of the sales of the group. The second important branch is the cardiovascular 
therapy, which makes 1/5th of total revenues.  
 
 
 
 
 
Figure 22 Therapeutic Areas of Chiesi farmaceutici S.P.A. 
Source: Annual Report of Chiesi farmaceutici S.P.A. 2008 
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5.4 The product life cycle of a pharmaceutical product 
 
 
Figure 23 The Respiratory Pipeline 
Source: Annual Report of Chiesi farmaceutici S.P.A. 2008 
 
 
As shown in Figure 23 the process beginning from the start of research and the 
usage of the remedy by the patient can be divided into three main steps. First the 
research phase is conducted. In this period of time there are several chemical 
mixtures experienced. Thus a substance is taken and the mechanism of action is 
tested. When the expected output is reached, the clinical proof of concept is started. 
During this time the active pharmaceutical ingredient is tested first on animals and 
then on people to receive an evidence of clinical efficacy and safety. After the 
development is complete the legal registration and launch of the product is started.  
 
A very important issue in the pharmaceutical sector is the letters patent. Because the 
exclusive rights for a medicine can be granted for a maximum of 20 years, depending 
on the country the patent is issued in, pharmaceutical companies have to push the 
research and learn phases, which in average take round about 10 years. Thus 
pharmaceutical firms have 5 years after the approval of the regulatory authorities to 
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make profits and to cover the expenses, which have risen during the first two phases. 
An example in this context would be Foster, a product of Chiesi farmaceutici S.P.A., 
which was launched in 2008 worldwide and in fact has not reached the break even 
point yet (Dr. Wofgang Harrer).  
 
When looking at the pharmaceutical market, as shown in table 3, one realizes that 
the top pharmaceutical company only has a worldwide market share of 7.6% with a 
turnover of 46.6 billion US$ (Website of ISM Health http://www.ismhealth.com; 
access date: 2010/04/30).  
 
Company Country Sales in US$ Market Share 
Pfizer USA 46.6 billion 7.6 % 
GlaxoSmithKline UK 37.4 billion 6.1 % 
Novartis CH 31.8 billion 5.2 % 
Sanofi-Aventis F 31.6 billion 5.2 % 
Johnson & Johnson USA 27.5 billion 4.5 % 
AstraZeneca UK 27 billion 4.4 % 
Merck & Co USA 25.1 billion 4.1 % 
Roche CH 23.9 billion 3.9 % 
Abbott USA 17.8 billion 2.9 % 
Amgen USA 16.3 billion 2.7 % 
 
Table 4  Sales and Market Share in the Pharmaceutical Industry (no Generics included) 
 Source: adapted from IMS Health, 2006  
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5.5 What kind of strategy does Chiesi farmaceutici S. P. A. apply? 
5.5.1 The Theory of Miles and Snow 
 
When looking at the strategy of Chiesi farmaceutici S. P. A., there can’t be any clear 
lines drawn, because as you can see below the visions and missions of the company 
can be identified in several forms of strategic typologies.  
 
Mission of Chiesi farmaceutici S. P. A.: 
 
• Our aim is to be recognised as a research-focused international Group, able to 
develop and commercialise innovative pharmaceutical solutions to improve the 
quality of human life. 
• We want to maintain a high quality entrepreneurial team characterised by self 
confidence and a collaborative spirit. 
• Our goal is to combine commitment to results with integrity, operating in a 
socially and environmentally responsible manner (Website of Chiesi 
farmaceutici S. P. A. http://www.chiesi.com; access date: 2010/04/14).  
Table 4 summarizes the main points and key terms of the company’s mission 
matched with the different strategic tools mentioned by Miles and Snow. Thus it 
can be said that Chiesi farmaceutici S. P. A. is not focusing at one special type of 
strategic manner but has several characteristics from the defender to the analyzer 
and prospector strategy.  
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Strategy Goal Structure 
Defender 
high quality 
entrepreneurial team, 
Centralized, formalization 
high, tight control 
Analyzer 
confidence and a 
collaborative spirit, 
operating in a socially and 
environmentally 
responsible manner 
Low centralized control but 
tight control over current 
activities 
Prospector 
research-focused 
international Group, 
develop and 
commercialise innovative 
pharmaceutical solutions 
Decentralized, 
formalization low, low 
division of labour  
Table 5  Strategy Typologies by Miles and Snow  Source: adapted from Robbins 
Stephan P. (1990)  
 
 
5.5.2 The Theory of Porter 
 
Porter's Three Competitive Strategies can be mentioned shortly, because the high 
cost of production (as mentioned in point 5.4) and the small number of industry 
segments (see figure 22) can only end in a focus-oriented competitive strategy. This 
is due to the niche positioning and setting the focus on the satisfaction of needs of 
the target group. 
 
5.5.3 The Theory of Perlmutter 
 
Whenever Chiesi farmaceutici S. P. A. acquired (or merged) with another company or 
opened a new subsidiary, the focus was set on leaving the affiliate quite 
independent. The approach was to leverage the local competencies and knowledge 
of the market and market condition. Local companies had their own portfolio and the 
corporate products from Chiesi farmaceutici S. P. A. were only added step by step. 
But during time the organizations were integrated slowly. Currently there is a 
common group strategy in terms of product portfolio and how to implement the 
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commercial strategy in the different countries. But leveraging still on the local 
competence and knowledge, which makes the strategy happen at the local level. This 
type of management behaviour can not be identified as one single but as a mixture of 
strategic methods.  
 
 Ethnocentrism Polycentrism Regiocentrism Geocentrism 
Mission   x x 
Authority;  
Decision making 
  x  
Structure    x  
Control    x 
Communication    x 
Recruiting  x  x 
Marketing    x x 
Finance x    
Table 6  Source: adapted from Perlmutter H. V. (1969) and Chakravarthy B. S. and Perlmutter 
H. V. (1985) 
 
5.5.4 The Theory of Hedlund 
 
In Hedlund’s theory the heterarchical MNC has its competitive advantage not only in 
one country, but in many, thus the firm has many centres. It can also be said that in 
excessive situations one single subsidiary is the centre for performances within one 
field.  
This is true for Chiesi farmaceutici S. P. A. because especially the office in Vienna 
has specialized in serving several different countries in Central and Eastern Europe.  
A further argumentation would be that the production plants are only located in Brazil, 
Italy and France. Thus there is a specialization in one single subsidiary which 
supplies the rest of the company.  
 
But for Hedlund also the flexibility of the organization plays an important role. A 
subsidy for example has the opportunity to decide weather it purchases components 
over headquarter or externally.  
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This is the case in Chiesi farmaceutici S. P. A. As some of the subsidiaries where 
integrated by mergers and acquisition they had a portfolio of products and licenses 
before Chiesi farmaceutici S. P. A. took over. These products and contracts were 
kept, to perform the business in the country as good as possible with the additional 
support of Chiesi farmaceutici S. P. A. 
 
Last but not least Hedlund (1984) mentions, that alliances with other firms are rather 
common in a company following the heterarchical mindset. Also this is true with 
Chiesi farmaceutici S. P. A., but I would say that this is due to the industrial sector, in 
which Chiesi farmaceutici S. P. A. is operating in. Dunning also argues that there are 
several reasons why alliances become more and more common. Some of them are 
in particular adaptive for pharmaceutical firms:  
 
• They enhance the significance of core technologies, 
• they increase the mutual dependence between individual technologies for joint 
supply of special products, 
• they abbreviate the product life cycle, and  
• they upgrade the core competencies to improve global competitive 
advantages (Rassmussen, 2002). 
 
But there are only four points which can also be found in Chiesi farmaceutici S. P. A. 
which Hedlund mentions when talking about the heterarchical MNC. All others cannot 
be found in this case study. Thus I can say that Chiesi farmaceutici S. P. A. shows 
some characteristics of a hypermodern MNC but some particular business sectors 
rest upon old structures.   
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5.6 The Structural Analysis of Chiesi farmaceutici S. P. A. 
 
The organizational chart of Chiesi farmaceutici S. P. A. is quite complex, because 
there are many subsidiaries acting quite independently but still with a degree of 
control. After analyzing the reporting structures and the mechanisms of control I can 
say that Chiesi farmaceutici S. P. A. is applying the matrix structure mentioned in 
point 3.2.5. 
 
Both foreign sales and product diversity are high in the matrix structure. Foreign 
sales are one of the main measurement tools of Chiesi farmaceutici S. P. A. 
Moreover product diversity is high. A good example is the distribution not only of 
products produced by Chiesi farmaceutici S. P. A. but also products in the medical 
supply. This allocation derives of a partnership with other pharmaceutical companies 
such as 3M, Pfizer or Abbott. This fact makes the product diversity high and improves 
market position.  
 
Another essential key factor is the one of local responsiveness and the global 
efficiency. Especially in the pharmaceutical industry the responsiveness plays an 
important role. On the website of Chiesi farmaceutici S. P. A. it is stated that the 
company is trying to go the “ethical and sustainable way”. This project is mainly 
focused in 4 big areas: Environmental efforts, endeavours for the patients, the 
wellbeing of the employees and the added value.  
An additional way for Chiesi farmaceutici S. P. A.  is to enforce the activities of the 
Chiesi Foundation, which has traditionally focused its attention on the company’s 
social responsibility and biomedical research directed towards the fight against 
chronic respiratory diseases and certain rare diseases. 
And all this efforts in responsibility of a special market are also divided by the product 
and area managers in all subsidiaries.  
 
The drawbacks mentioned by Daft (1995) can also be found in Chiesi farmaceutici S. 
P. A.  In an unofficial interview with a manager she told me that the decision making 
process takes too long and that the structure is too tight. In addition the overload of 
reporting makes the company inflexible and stiff. This is because the managers in the 
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different areas have to report to 2 different persons, one in the same country and one 
in the same specific area of the company but located in the home country in Italy.  
 
Below the organisational chart of Chiesi farmaceutici S. P. A. is illustrated.  
 
Figure 24 Organisation chart of Chiesi farmaceutici S.P.A. (fragmented) 
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5.7 Does the Triad Power exist for Chiesi farmaceutici S. P. A.? 
 
First of all we have to review the regions and countries Chiesi farmaceutici S.P.A. is 
acting in. As already mentioned before, the core region of Chiesi is in Europe. Chiesi 
covers round 90% of Europe either through direct presence or through partners. The 
rest of the world is not that comprehensively covered. The first subsidiaries, which 
were opened up outside of Europe were in Pakistan and Brazil in the 1980ies. But 
these countries do not belong to the triad power according to Segal-Horn and 
Faulkner (2000) because the triad power is located in Europe, North America and 
Asia (especially Japan).  
Since 2004 Chiesi farmaceutici S.P.A. is also operating in the United States 
(Maryland, directly and North Carolina, partnership) and since 2008 in Mexico. This 
region is covered through an independent subsidiary of the company 
(http://www.chiesigroup.com/web/guest/chi-siamo/il-gruppo-chiesi/chiesi-nel-
mondo?idt=166688). 
The group is also operating in Asia, although it is not Japan but business was started 
in Shanghai, China in 2008. 
 
When considering Kenichi Ohmae’s theory, one can say that the triad power is not 
existing for Chiesi farmaceutici S.P.A. because the focus of the group is set on 
business in Europe. Since two years the company is trying to gain ground in North 
America and in Asia, but with a focus on China instead of Japan.  
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5.8 Conclusion 
 
Chiesi farmaceutici S.P.A. is truly a multinational company. But is it also global? I 
would say no, it is not according to Perlmutter and Hennan (1979), because Chiesi 
farmaceutici S.P.A. has a lot of a globally acting firm but with a lot of regiocentric 
acting. For the employees working for this company it can be said that the firm is 
applying a geocentric style, because control, communication and recruitment are 
global. This means that standards are universal and local due to the products Chiesi 
is offering, communication is in both directions and between the subsidiaries, and 
that the best man counts, no matter of the nationality.  
But fields such as the decision making and the structure are regiocentric. The main 
decisions are made in headquarter and then mutually negotiated between the 
regional Headquarter and the subsidiaries. The structure is a Matrix, which has 
advantages but also disadvantages. I think the most important disadvantage for a 
pharmaceutical company is that with a matrix structure it is not able to act fast 
enough on changing situations in the market. Due to the research and development 
needed to produce pharmaceuticals, when there are several firm trying to bring out 
the medicine first, it is very important to be flexible enough to act when another firm 
brings out the medication first.  
The department of finance of Chiesi is eye-catching because it is the only 
ethnocentric one. This is also due to the high degree of research necessary. All 
profits of the subsidiaries are returned to headquarter because the costs of clinical 
studies are high and take nearly ten years. Thus all returns are send back to Parma, 
which for the next year are divided according to the budget forecasts.   
 
I can see a high potential for Chiesi in the next view decades. The only barrier which I 
can detect is that Chiesi expands too fast in different countries and areas and the 
costs for growth in the different markets are not related to the profits gained.  
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9. Appendix 
 
 
9.1 Interview with Mr. Alessandro Chiesi and Mr. Wolfgang Harrer 
(on 12th of March 2010): 
 
 
Neda Gharib-Norsen: How did Chiesi expand in the foreign markets? 
Alessandro Chiesi: We are an Italian company. After serving the Italian market, we 
started export activities. And this was done by finding distributors in this and that 
country all over the world. Then there were a couple of early investments abroad, 
which were placed more than 20 years ago, one in Brazil and one in Pakistan. And 
they were out of any strategic picture. There was an opportunity to go to Brazil and 
let’s go to Pakistan. Let’s place a direct, a commercial organization there, in terms of 
direct investment. Until the 90ies we didn’t expand. Later, in the beginning of the 
90ies we defined the strategy to become a European group with direct commercial 
presence in all European countries. And so we started to enter into the different 
markets, starting with the big markets such as Great Britain and France and then 
later on the smaller ones. And this was done through acquisitions. So acquiring small 
companies in each market and making them our platform to market the group-
products.  
Neda Gharib-Norsen: So in Europe there was no foreign direct investment? Or was 
it mergers and acquisitions? 
Alessandro Chiesi: In the major countries we made acquisitions in order to build up 
some critical mass since the beginning. We started from scratch in couple of 
countries like Greece, our own organization; we started from scratch in a way in the 
Netherlands and also in Turkey, when you consider this as being part of Europe.  
Neda Gharib-Norsen: But all others were acquisitions?  
Alessandro Chiesi: Yes, of local companies. One exception if you want is Austria 
because here the company was already covering the different countries in the region.  
Wolfgang Harrer: So it was a country which already had own affiliates.  
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Neda Gharib-Norsen: So when you bought them all, how was the management? Did 
you interfere into the management style at the beginning? 
Alessandro Chiesi: Not so much. We had them quite independent. This was the 
approach: to leverage on the local competencies and knowledge of the market and 
market condition. 
Neda Gharib-Norsen: So you trusted them? 
Wolfgang Harrer: Here I can also comment let’s say from the other side, being a 
member of those companies which were acquired, there was even a very unusual 
flexibility and freedom in the local decisions. Because it was also a matter of local 
companies, that had their own portfolio and the corporate products were only added 
gradually, of course due to the long registration timelines and so this is a long lasting 
process of merging into a real group which now with Foster in my view is really the 
first very solid corporate strategy focusing on one product which also brings the 
affiliates together with the Headquarter much more in one line according the strategy.  
Neda Gharib-Norsen: When you are talking about the affiliates, is it the affiliates of 
Austria or the ones of the group? 
Wolfgang Harrer: No, it’s the one of the group.  
Neda Gharib-Norsen: So there is a standardized procedure chosen by Chiesi. But 
the affiliates still can act quite freely.  
Alessandro Chiesi: Well, this was the approach when we acquired and merged the 
affiliates. Then during time, we also integrated the organizations. So now we have a 
common group strategy in terms of product portfolio and how to implement the 
commercial strategy in the different countries. But leveraging still on the local 
competence and knowledge, which makes the strategy happen at the local level. The 
other point which is in my opinion very important is that while we were let’s say 
integrating more and more it was not only a top down approach. We tried and we are 
involving the local organizations in the definition of the strategy, in the definition of 
the processes. And I think this is not always common in the multinational groups. We 
have a number of processes or working groups, committees, all the organizational 
structure, involving, to the extend possible, representatives of the local market 
companies, in order to bring their experience on board, but also their needs. There is 
also a way to make them buy in the concept, because they have to participate to 
build up the strategy.  
 
 77
Neda Gharib-Norsen: How is the organizational chart structured? 
Alessandro Chiesi: We have a Matrix structure. There is a functional reporting 
system to the corporate Headquarter. The hierarchical one is to the director in the 
affiliates.  
Neda Gharib-Norsen:  What about the information and the Know-How? Is the 
information flow just up-down or also bottom-up? 
Alessandro Chiesi: R&D is at the corporate level.  
Neda Gharib-Norsen: So there is no Know-How the affiliates could gather to support 
the mother company? 
Alessandro Chiesi: Do you mean the intellectual property?  
Neda Gharib-Norsen: Yes and all other forms of Know-How, which is important for 
the company. 
Alessandro Chiesi: Intellectual property is created at the group level. 
Wolfgang Harrer: If you think about the R&D, this is done at the corporate level and 
is guarded totally at this level.  
Alessandro Chiesi: Regulatory activities are all run at the local level because you 
still need this double-layer activity.  
Neda Gharib-Norsen: But there are no needed adoptions to serve the different 
countries? The product is the same all over the world. 
Alessandro Chiesi: The product is standardized. At least at this moment it’s like 
that.  
 
Neda Gharib-Norsen: What about the marketing strategy? I know that 
pharmaceutical companies can’t advertise their products in TV but what about the 
marketing strategy? Do they differ in the different countries?  
Alessandro Chiesi: For the corporate products, particularly the last ones, the 
marketing strategy is one. And this is defined at the corporate level but as I said we 
want the affiliates to participate, which doesn’t mean that each and single affiliate will 
be able to participate, because then it’s not a democracy but chaos. But we still have 
created a number of tools and systems, organizational tools I mean, in order to get 
them on board and get their input. And also to share the best experiences, the best 
practices to be able to spread them around. This is where the strategy is coming 
from. The implementation is left to the single operative units with the level of flexibility 
which depends on the product and the situation. Sometimes we have more 
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sometimes less. But again compared to what the big multinationals are doing, this is 
the feedback we get; the affiliates are much more on board and much more 
participating deciding the things which count.  
Neda Gharib-Norsen: So culture and mentality does play a role in the company? 
Alessandro Chiesi: Yes.  
Neda Gharib-Norsen: Is there an Italian mentality as well? Is there an corporate 
culture so to say?  
Alessandro Chiesi: I can’t say it because I’m Italian. Maybe someone who is not 
should answer the question. 
Wolfgang Harrer: Yes, of course all companies, according to my very personal 
experience, they do have a kind of national mentality because I was previously 
working in a multinational company, which had its Headquarter in Germany. In some 
small details of the behaviour, of the relationship among people you see differences 
whether the Headquarter is in Germany or in Italy or in the US or eventually in India. 
So yes! I think these things are carried by individuals in the end of the day. When you 
have a Germany based Headquarter, there are mainly Germans, so of course the 
mentality is reflected in the relationship. 
 
Neda Gharib-Norsen: And what about the management? Is the management always 
from the same country? Or do you have expatriates being sent from Italy to the 
subsidiaries?  
Alessandro Chiesi: Usually we kept at the beginning the management. Then of 
course the organization developed. But we are leveraging on local management. So 
in France we have French management, French people, French General Manager in 
Germany the same, in Austria the same, so on and so forth. Recently, we think that 
this is the positive process, we started to have people from the Headquarter going 
either on mission or also on fix positions in the affiliates. I have to say that we are still 
a relatively small company, we have 3500 people, and we have to find the possibility 
to take a key person and send this person in an affiliate for couple of years is not 
easy because you miss the person at the Headquarter. What was not possible so far 
was, or better: there are couple of cases so far people coming from the affiliates 
going to the Headquarter. We would like to have more, but this is not always easy 
with the Italian mentality. People refuse to go. You can see it as an opportunity or as 
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a problem. In Italy they are not used to move from their city. It is not easy to convince 
people.  
Neda Gharib-Norsen: So the philosophy is the best people no matter where they are 
from on the best positions? 
Alessandro Chiesi: As I said, we are leveraging on a local management. Our 
manager is local, also because we need people who know the local features of the 
market and the county. 
Neda Gharib-Norsen: But if Mr. Harrer for example would like to come to Italy and 
life there you would accept it, when having the right position? 
Alessandro Chiesi: We don’t have anything against it. We are nowadays trying to 
stimulate to people to go abroad.  
Neda Gharib-Norsen: To be more multinational? 
Wolfgang Harrer: Yes.  
 
Neda Gharib-Norsen: What about the surplus of the subsidiaries? Do the 
subsidiaries keep the surplus in their country or do they transfer it to the mother-
company? 
Alessandro Chiesi: No, they transfer it to the mother-company.  
Neda Gharib-Norsen: And you choose the budget, which is divided again? When 
Austria has for example a surplus, do they transfer it back to the mother-company, 
which in turn chooses the budget for the next year? 
 Wolfgang Harrer: No it is different. Actually in the pharmaceutical industry you need 
high financial resources for the R&D, which is done on the corporate level. So the 
dividends are also among others used for lets say the development of the company, 
so for the R&D activities, eventually for new acquisitions or new developments. Then 
separate from this general financial issue, you have the normal standardized 
budgeting process, which is a suggestion and an agreement planning process, as 
done in every other company. We do have this twice a year. Then we have the 
forecast process, which we have right now, and then we have the final budgeting 
process, which is finished roughly in November every year for the next year. But the 
financial resources are not linked to that. Basically you are talking about local money 
and local business and the local resources. And theoretically if needed there is the 
possibility of receiving a loan if the liquidity makes it necessary on the one hand or if 
there is a surplus you are paying dividends back to the Headquarter.  
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Alessandro Chiesi: To add one point because I think this is an important one, if I 
understood your question right. The decision in terms of what to invest and where to 
invest is made at the group-level. So at the end of the day you can say that the 
resources created by the whole group for the affiliates are pooled at the group-level 
and then it’s the group deciding weather next year we will invest, make an acquisition 
by an product or what ever in this or that country. So if Austria tomorrow needs 10 
times what they are able to create or generate in terms of yearly income to make an 
investment, this will be decided and done independently from the ability of the single 
market to generate this income. Under this aspect we are acting on a global point of 
view.  
 
Neda Gharib-Norsen: What about the visions and missions?  
Alessandro Chiesi: They are the same all over. 
 
Neda Gharib-Norsen: Ok. Last question: Did you ever have the feeling the company 
grew too fast?  
Alessandro Chiesi: No. 
Neda Gharib-Norsen: So there were no situations you couldn’t cope with?  
Alessandro Chiesi: No. I don’t think so. I think as an approach and as an outcome 
at the end of the day our company has followed a successful but still balanced 
growth button. This doesn’t mean that you are always 100% in line with the needs. 
Sometimes you are more advanced, sometimes you are lacking behind and trying to 
cope and trying to catch up.  
Wolfgang Harrer: The question is why should a company grow too fast? I can only 
see two reasons, why one could say we are growing too fast. On the one hand it’s 
the financial reason, that you are deluding your financial capability, which in Chiesi 
according to my knowledge was never the case. And on the other hand the people 
and structure, so when saying my business is growing quicker that I can get 
management experience, which I would say that we have a live case in our business 
in Poland, where we are launching the most important launch currently and we are 
growing from a small unit of 40 people a year ago and we will be 160 people this 
year. This is a challenge. It is an interesting thing, but you can recruit the right 
people. We did the major recruitments already. The HR-mission in this case is very 
much more different from a normal growth, which is done usually. But it’s possible, 
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and I would not say that we are growing too fast. When you see the opportunity, and 
try to adopt the structure according to the necessities to catch the opportunity.  
Neda Gharib-Norsen: As far as I know the history of the company, especially in the 
90ies and at the Millennium there was a big expansion of the group, as far as I know.  
Alessandro Chiesi: We were making these acquisitions and creating this European 
network. 
Neda Gharib-Norsen: And this worked out fine? 
Alessandro Chiesi: Yes it worked out fine.  It was balanced of a financial point of 
view as Wolfgang said and of the organizational point I think that it was challenging, 
because we really had to run a lot. But still I think when you look at how we were ten 
years ago and how we are right now in terms of organization I think that a big change 
was made. And the group is solid. I know there are companies growing by 
acquisitions in the very last years in our sector, small and medium companies, when 
you think about Almeda or these Icelandic companies. They are not a group. Possibly 
they have some other financial tensions nowadays. But we will see in the US, maybe 
this will be a more challenging story.  
 
Neda Gharib-Norsen: You said you want to be European company. But Europe is 
covered now.  
Alessandro Chiesi: We made it, because we are now covering 95% of Europe with 
direct presence. And this presence is to a good extend aligned. So we have reached 
critical mass almost everywhere. And portfolio products are getting aligned again. 
Now the next step is to extend to other promising markets. For the pharmaceutical 
market this is the U.S., which represents 60% of the worldwide market. Then markets 
like China, where we started 2 years ago. We also have a presence in Brazil. Russia 
is still a question mark. It’s a country at its own. Our presence there still has to be 
developed. And what is also important, is that our aim is for the current products, 
which are being developed now, to develop them worldwide, which means not only to 
make the development for Europe until yesterday but also make the development in 
such a way to make the registration possible in the U.S. We are talking about the 
products in our core area, we are a respiratory company, so for niche strategic areas. 
The future product should be registered possibly also in other big markets worldwide.   
Wolfgang Harrer: For your understanding, it’s still the same product with the same 
indication, the same dosiging and so on. But what you have here is on the one hand 
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the different requirements from the local authorities, so eventually you need more 
data here or more specific data here in order to support your application for the 
registration. Or eventually this is a small technical detail you have due to the different 
climate zones. You have different qualitative aspects. Brazil is different according to 
the temperature than Russia. And this is also reflecting in the quality categories, 
which we have to consider in this development.  
Alessandro Chiesi: This doesn’t mean that the strategy will be the same, because 
while for specialty therapeutic areas, very special, very niche if you want, we can 
think to do at our own, because we don’t need a big infrastructure or big investment, 
when you come to larger markets, where you need larger commercial organization 
for instance, maybe to go for an partnership.  
Neda Gharib-Norsen: Is there any partnership? 
Alessandro Chiesi: We have partnerships in many many countries. Some of them 
are small ones if you want. The early stage ones, but recently we have important 
partnerships for markets that either we don’t cover directly or we are covering but 
where we need more critical mass in terms of commercial infrastructure, and so you 
can decide to have a partner to co-promote and co-sell. 
Neda Gharib-Norsen: Is it like in northern Africa? Morocco I think. 
Alessandro Chiesi: There we have a presence, which is a kind of direct presence 
simply structured in a way to reduce our spousal risk and commitment. So leverage 
on local rented fee forces, but we manage them on our own. The management is 
ours, the fee forces are rented, and then we are exporting as we are also doing in 
countries in Eastern Europe. So it’s a presence which can be defined as a direct 
affiliate but a more virtual one due to different reasons, risks and situations of this 
specific country. In that case it’s Chiesi acting. But if you go to South Korea, an 
interesting market for respiratory products, we have a local company there marketing 
our products. The same is in Australia, South Africa or any external partner.  
Wolfgang Harrer: But we also have partners for countries where we already have 
our own local affiliates.   
Alessandro Chiesi: In Germany Foster is our main product but there is a second 
brand which is marketed by another company. This is the way they market products 
in the pharmaceutical world so far. It’s called co-marketing.  
Wolfgang Harrer: But we have no global partnership.  
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10. Abstract 
 
The strategy of every Multinational Company is an important issue; a corporation has 
to consider being successful. But many companies forget about this.  
 
Thus this paper has the aim to give a short overview over the different strategic 
orientations and structures of multinational firms. The first part of this thesis 
concentrates on the theory. First the different strategic methods are reviewed. The 
diverse strategic theories of Chandler’s Strategy-Structure Thesis, Miles and Snow’s 
Four Strategic Types, Porter’s Competitive Strategies and Perlmutter and Heenan`s 
EPRG Model are discussed in detail. A special focal point is set on the Ethocentric-
Polycentic-Regiocentric-Geocentric Model because this in my eyes is the best 
strategic analysis of multinational companies, because this model not only views one 
special department or branch of the company but judges the firm as one organization 
which is linked.  
Secondly the structures are reviewed. The structural analysis begins with the 
evolutionary Models of  Stopford and Wells, Daniels, Pitts and Tretter and finally with 
the Model by Egelhoff. Then I give a short overview over the traditional structure 
figures. Again I set my focus on one special survey by Bartlett and Goshal.  
 
The second part of this thesis is a practical one. The theoretic background is revolved 
on Chiesi farmaceutici S.P.A., which is a pharmaceutical multinational with the 
Headquarter located in Parma, Italy.  It can be seen how a pharmaceutical company 
which was founded in 1935 grew worldwide and how this affected the structure and 
strategy of this company. This was done by an expert-interview with Allesandro 
Chiesi (Affiliate Coordinator International Division, Parma) and Wolfgang Harrer 
(Managing Director, Austria) in Vienna. 
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10.1 Zusammenfassung  
 
Die Strategie eines jeden multinationalen Konzerns ist eine wichtige Angelegenheit; 
ein Unternehmen darf den Erfolg nie außer Acht lassen. Viele vergessen dies jedoch! 
 
Diese Diplomarbeit versucht einen kurzen Überblick über die verschiedenen 
strategischen Ausrichtungen und Strukturen von multinationalen Unternehmen zu 
geben. Der erste Part der Diplomarbeit beschäftigt sich mit der Theorie.  Zuerst 
werden die unterschiedlichen strategischen Methoden rezensiert. Die verschiedenen 
strategischen Theorien von Chandler’s Strategy-Structure Theorie, Miles und Snow’s 
vier Strategietypen, Porter’s Wettbewerbsstrategien und Perlmutter und Heenan`s 
EPRG Model werden hier im Detail besprochen. Ein besonderes Augenmerk wird 
hier auf das Ethocentric-Polycentic-Regiocentric-Geocentric-Modell gesetzt, da dies 
meiner Meinung nach die beste Strategieanalyse mulinationaler Unternehmen ist. 
Dies ist möglich, da bei diesem Model nicht nur ein bestimmter Bereich oder 
Abteilung betrachtet wird sondern der Konzern wird als eine gesamtheitliche 
Organisation betrachtet.   
Als nächstes werden die Strukturen beschrieben. Die Strukturanalyse beschäftigt 
sich beginnend mit dem Evolutionsmodel von  Stopford und Wells, Daniels, Pitts und 
Tretter und schlussendlich mit dem Model von Egelhoff. Danach gebe ich eine kurze 
Übersicht über die traditionellen Organisationsstrukturen. Auch hier lege ich mein 
Augenmerk auf die Erkenntnisse Bartlett und Goshal.  
 
Der zweite Teil der Diplomarbeit ist praktisch ausgelegt. Das vorher angeeignete 
theoretische Wissen wird dann auf Chiesi farmaceutici S.P.A., ein pharmazeutischer 
multinationaler Konzern mit Sitz in Parma, umgewälzt. So ist zu erkennen wie ein 
Pharmaunternehmen, das in 1935 gegründet wurde, weltweit expandierte und wie 
dies die Struktur und Strategie des Unternehmens beeinflusste. Dies wurde durch ein 
Experteninterview mit Allesandro Chiesi (Affiliate Coordinator International Division, 
Parma) und Wolfgang Harrer (Managing Director, Austria) in Wien bewerkstelligt. 
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